Unlock instant, AI-driven research and patent intelligence for your innovation.

Azaspirone pharmaceutical composition and preparation method thereof

A composition and compound technology, applied in the directions of drug combination, drug delivery, pharmaceutical formulation, etc., to achieve the effect of reducing adverse reactions, shortening production cycle, and low content of related substances

Active Publication Date: 2017-07-21
SICHUAN CREDIT PHARMA
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are currently no relevant literature reports on the causes of the above adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Azaspirone pharmaceutical composition and preparation method thereof
  • Azaspirone pharmaceutical composition and preparation method thereof
  • Azaspirone pharmaceutical composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] 1. Preparation of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide

[0047] Prepare cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide according to the method reported in the literature (China New Technology and New Products. 2014,8,13), and its The content of related substances is 2.7%. Among them, the HPLC (High Performance Liquid Chromatography) test conditions are: use octadecylsilane bonded silica gel as filler, 0.01mol / L potassium dihydrogen phosphate solution (adjust pH to 7.5 with 10% sodium hydroxide solution)-acetonitrile (80:20) is the mobile phase, the detection wavelength is 243nm, and the measured purity is 97.3%.

[0048] 2. Purification of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide

[0049] (i) Weigh 100.0 g of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide prepared in the above step 1, add a mixed solvent of 400 mL ethanol and 400 mL water, and heat to solvent reflux , after stirring for 1 hour, lower the temperature to 50±5°C and stir for 1 hour, ...

Embodiment 2

[0058] Using cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide prepared under the conditions of 1-5 in Table 1 as raw material, prepare tandospirone citrate according to the above method The composition, as tested by HPLC, shows that the content of tandospirone citrate is above 98.0%, and the contents of related substances are shown in Table 2.

[0059] Table 2. Test results

[0060]

[0061]

[0062] Note: "--" means not detected.

[0063] From the above, it can be known that the purification process of the intermediate cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide in Examples 1 and 2 uses environmentally friendly, safe, low-toxic / non-toxic reagent, and has the advantages of high yield and high purity; in addition, the preparation of the tandospirone composition adopts a two-step one-pot process, without the need to separate the intermediate products generated by the reaction, which greatly improves the industrial production efficiency and shortens the production cycle...

Embodiment 3

[0065] 1. The preparation of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide is the same as Step 1 of Example 1.

[0066] 2. Purification of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide

[0067] (i) Weigh 100.0 g of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide prepared in the above step 1, add a mixed solvent of 400 mL ethanol and 400 mL water, and heat to solvent reflux , stirred for 1 hour, cooled naturally to room temperature, placed at -10±5°C for 2 to 3 hours, filtered with suction, added a mixed solvent of 200 mL of ethanol and 200 mL of water to the filter cake, heated to solvent reflux, stirred for 1 hour, and naturally cooled to room temperature. Place at 5±5°C for 2-3 hours, filter, and dry the filter cake to obtain 99.5 g of cis-exo-bicyclo[2.2.1]heptane-2,3-dicarboximide with a yield of 99.5%. The purity measured by HPLC is greater than 99.5%, and the detection conditions are the same as step 1 of Example 1, wherein, impurity 1 (cis-exo-bicyclo[2.2.1]hept-5-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an azaspirone pharmaceutical composition and a preparation method thereof. The azaspirone pharmaceutical composition comprises a compound I and / or citrate thereof, a compound II and / or citrate thereof and a compound III and / or citrate thereof, and has anxiolytic and anti-depression effects, and small adverse reaction. The product prepared by the preparation method has high purity and low content of related substances.

Description

technical field [0001] The invention relates to an azaspirone pharmaceutical composition and a preparation method thereof. Background technique [0002] Tandospirone belongs to the class of azaspirone drugs, the chemical name is (3aα,4β,7β,7aα)-hexahydro-2-[4[4-(2-pyrimidinyl)-1-(piperazinyl)- Butyl]-4,7-methylene-1H-isoindole-1,3(2H)-dione. It is a serotonin receptor agonist and belongs to the third generation of anxiolytic drugs, mainly used for the treatment of anxiety or other diseases accompanied by anxiety state. Tandospirone can highly selectively interact with 5-HT that is concentrated in the hippocampus, septum, interpeduncular nucleus, amygdala and other brain limbic systems and suture gland nuclei in the emotional center. 1A Receptor binding, stimulant 5-HT 1A Autoreceptors, play an anxiolytic effect. Tandospirone can also play a certain antidepressant effect. [0003] Compared with its similar derivative buspirone, tandospirone has a higher selective anxioly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/506A61P25/22A61P25/24C07D209/76
CPCA61K31/506C07D209/94A61K9/2059A61K9/2054A61K9/1652A61K9/0002A61K9/006C07B2200/07A61K2300/00
Inventor 陈刚李晓莉刘志鸿傅霖
Owner SICHUAN CREDIT PHARMA